- Home
- NKTR vs NAC Comparison
NKTR vs NAC Comparison
Compare NKTR & NAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NKTR | NAC |
|---|---|---|
| Founded | 1990 | 1998 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.8B |
| IPO Year | 1996 | 1998 |
Fundamental Metrics
Financial Performance| Metric | NKTR | NAC |
|---|---|---|
| Price | $58.00 | $10.24 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $146.67 | N/A |
| AVG Volume (30 Days) | 964.5K | ★ 1.2M |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.33% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $307,711,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 86.00 | N/A |
| 52 Week Low | $33.40 | $10.19 |
| 52 Week High | $109.00 | $12.25 |
Technical Indicators
Market Signals| Indicator | NKTR | NAC |
|---|---|---|
| Relative Strength Index (RSI) | 33.78 | 24.81 |
| Support Level | $54.13 | N/A |
| Resistance Level | $76.63 | $12.04 |
| Average True Range (ATR) | 3.68 | 0.24 |
| MACD | -1.13 | -0.04 |
| Stochastic Oscillator | 10.35 | 5.47 |
Price Performance
Historical ComparisonAbout NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.
About NAC Nuveen California Quality Municipal Income Fund
Nuveen California Quality Municipal Income Fund is a closed-end fixed income mutual fund that prominently invests in tax-exempt municipal bonds from California. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Arizona individual income taxes. Its portfolio mainly includes investment-grade municipal securities of California. The fund targets various sectors such as healthcare, utilities, transportation, and consumer staples.